These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27010254)

  • 41. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
    Hasegawa T; Yamakado K; Nakatsuka A; Uraki J; Yamanaka T; Fujimori M; Miki M; Sasaki T; Sakuma H; Sugimura Y
    Radiology; 2015 Nov; 277(2):584-93. PubMed ID: 25997031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors.
    Berber E; Siperstein A
    Ann Surg Oncol; 2008 Oct; 15(10):2757-64. PubMed ID: 18618182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
    Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
    Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802).
    Hasegawa T; Takaki H; Kodama H; Matsuo K; Yamanaka T; Nakatsuka A; Takao M; Gobara H; Hayashi S; Inaba Y; Yamakado K
    J Vasc Interv Radiol; 2023 Jan; 34(1):31-37.e1. PubMed ID: 36209996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
    Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
    Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
    Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system].
    Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
    Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone.
    Staal FCR; Taghavi M; van der Reijd DJ; Gomez FM; Imani F; Klompenhouwer EG; Meek D; Roberti S; de Boer M; Lambregts DMJ; Beets-Tan RGH; Maas M
    Eur J Radiol; 2021 Aug; 141():109773. PubMed ID: 34022475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
    Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
    Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.